Drug induced phospholipidosis: An acquired lysosomal storage disorder

作者：Shayman James A^*; Abe Akira

来源：Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 2013, 1831(3): 602-611.

DOI：10.1016/j.bbalip.2012.08.013

• Lysosome
• Phospholipase A2
• Drug induced phospholipidosis
• Cationic amphiphilic drug
• Amiodarone

There is a strong association between lysosome enzyme deficiencies and monogenic disorders resulting in lysosomal storage disease. Of the more than 75 characterized lysosomal proteins, two thirds are directly linked to inherited diseases of metabolism. Only one lysosomal storage disease, Niemann-Pick disease, is associated with impaired phospholipid metabolism. However, other phospholipases are found in the lysosome but remain poorly characterized. A recent exception is lysosomal phospholipase A2 (group XV phospholipase A2). Although no inherited disorder of lysosomal phospholipid metabolism has yet been associated with a loss of function of this lipase, this enzyme may be a target for an acquired form of lysosomal storage, drug induced phospholipidosis. This article is part of a Special Issue entitled Phospholipids and Phospholipid Metabolism. Published by Elsevier B.V.

• 出版日期2013-3